Institute for Clinical & Economic Review Report Evaluates Clinical Value and Pricing of Entyvio for Inflammatory Bowel Diseases
2026-03-19
TNS-Reports2026-03-19
Targeted News Service
WASHINGTON, March 19 (TNSLrpt) -- Special Assessment to Inform CMS Drug Price Negotiations: Vedolizumab (Entyvio) for Ulcerative Colitis and Crohn's Disease - A report from Institute for Clinical and . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, March 19 (TNSLrpt) -- Special Assessment to Inform CMS Drug Price Negotiations: Vedolizumab (Entyvio) for Ulcerative Colitis and Crohn's Disease - A report from Institute for Clinical and . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026